nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.000777	0.000777	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EP300—ocular cancer	0.000753	0.000753	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—MYC—ocular cancer	0.000735	0.000735	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by Wnt—AKT1—ocular cancer	0.000734	0.000734	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TGFB1—ocular cancer	0.000733	0.000733	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GNA11—ocular cancer	0.000718	0.000718	CbGpPWpGaD
Pseudoephedrine—SLC6A4—NRF2 pathway—TGFB1—ocular cancer	0.000716	0.000716	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000715	0.000715	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HDAC1—ocular cancer	0.000711	0.000711	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—EP300—ocular cancer	0.000707	0.000707	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—HRAS—ocular cancer	0.000704	0.000704	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—TGFB1—ocular cancer	0.000678	0.000678	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—EP300—ocular cancer	0.000674	0.000674	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.000669	0.000669	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—ocular cancer	0.000669	0.000669	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GNAQ—ocular cancer	0.000667	0.000667	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000654	0.000654	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000653	0.000653	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PSPH—ocular cancer	0.000643	0.000643	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00064	0.00064	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—EP300—ocular cancer	0.000638	0.000638	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CDKN2B—ocular cancer	0.000637	0.000637	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—ocular cancer	0.000633	0.000633	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000623	0.000623	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—AKT1—ocular cancer	0.000622	0.000622	CbGpPWpGaD
Pseudoephedrine—SLC6A2—NRF2 pathway—TGFB1—ocular cancer	0.000615	0.000615	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TGFB1—ocular cancer	0.000615	0.000615	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000608	0.000608	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—ocular cancer	0.000603	0.000603	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000603	0.000603	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HDAC1—ocular cancer	0.000601	0.000601	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—E2F1—ocular cancer	0.000585	0.000585	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000574	0.000574	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—AKT1—ocular cancer	0.000573	0.000573	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—MYC—ocular cancer	0.000554	0.000554	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TGFB1—ocular cancer	0.000553	0.000553	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MDM2—ocular cancer	0.000547	0.000547	CbGpPWpGaD
Pseudoephedrine—SLC6A3—NRF2 pathway—TGFB1—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CDKN2B—ocular cancer	0.000539	0.000539	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—AKT1—ocular cancer	0.000534	0.000534	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—HRAS—ocular cancer	0.000515	0.000515	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—ocular cancer	0.000506	0.000506	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MDM2—ocular cancer	0.000505	0.000505	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—MDM2—ocular cancer	0.000501	0.000501	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.0005	0.0005	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—GNA11—ocular cancer	0.000499	0.000499	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CDKN1B—ocular cancer	0.000499	0.000499	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000499	0.000499	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—E2F1—ocular cancer	0.000495	0.000495	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—ocular cancer	0.000485	0.000485	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—ocular cancer	0.000484	0.000484	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SAG—ocular cancer	0.000474	0.000474	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—MDM2—ocular cancer	0.000466	0.000466	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—GNAQ—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SAG—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MDM2—ocular cancer	0.000462	0.000462	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CDKN1B—ocular cancer	0.000461	0.000461	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CDKN1A—ocular cancer	0.000461	0.000461	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—ocular cancer	0.000456	0.000456	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—ocular cancer	0.000455	0.000455	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—AKT1—ocular cancer	0.000455	0.000455	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CDK4—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—ocular cancer	0.000447	0.000447	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EP300—ocular cancer	0.000438	0.000438	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—AKT1—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CDKN1A—ocular cancer	0.000425	0.000425	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CDKN1B—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GNA11—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—E2F5—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PSPH—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HDAC1—ocular cancer	0.000418	0.000418	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—E2F4—ocular cancer	0.000411	0.000411	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GNA11—ocular cancer	0.000411	0.000411	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00041	0.00041	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—E2F5—ocular cancer	0.00041	0.00041	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—ocular cancer	0.00041	0.00041	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EP300—ocular cancer	0.000405	0.000405	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RBL1—ocular cancer	0.000403	0.000403	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—E2F4—ocular cancer	0.000402	0.000402	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RBL1—ocular cancer	0.000394	0.000394	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GNAQ—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CDKN1A—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—AKT1—ocular cancer	0.000384	0.000384	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SAG—ocular cancer	0.000383	0.000383	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GNAQ—ocular cancer	0.000382	0.000382	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GNA11—ocular cancer	0.000381	0.000381	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GNA11—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EP300—ocular cancer	0.000371	0.000371	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SAG—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GNAQ—ocular cancer	0.000354	0.000354	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MDM2—ocular cancer	0.000354	0.000354	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MYC—ocular cancer	0.000353	0.000353	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFB1—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—E2F3—ocular cancer	0.000349	0.000349	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GNAQ—ocular cancer	0.000347	0.000347	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—E2F3—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GNA11—ocular cancer	0.00034	0.00034	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—E2F5—ocular cancer	0.000339	0.000339	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—E2F4—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RBL1—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TFDP1—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CDKN1B—ocular cancer	0.000323	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TFDP1—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GNAQ—ocular cancer	0.000316	0.000316	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GNA11—ocular cancer	0.000316	0.000316	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—E2F5—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—E2F4—ocular cancer	0.000309	0.000309	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GNA11—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCND1—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GNA11—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RBL1—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—ocular cancer	0.0003	0.0003	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MDM2—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CDKN1A—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—CDK2—ocular cancer	0.000297	0.000297	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GNAQ—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GNAQ—ocular cancer	0.000287	0.000287	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GNA11—ocular cancer	0.000287	0.000287	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EP300—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—E2F3—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GNAQ—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000281	0.000281	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CDKN1B—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EP300—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GNAQ—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TFDP1—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—E2F3—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCND1—ocular cancer	0.00026	0.00026	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAML2—ocular cancer	0.000258	0.000258	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAML2—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CDKN1A—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MYC—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFB1—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TFDP1—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EP300—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—TGFB1—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GNA11—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GNA11—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GNAQ—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MYC—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAML2—ocular cancer	0.000209	0.000209	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFB1—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GNAQ—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GNA11—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAML2—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HDAC1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GNAQ—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HDAC1—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNA11—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNAQ—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNA11—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN2B—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—EP300—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN2B—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—ocular cancer	0.000162	0.000162	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNAQ—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—E2F1—ocular cancer	0.000155	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HDAC1—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—E2F1—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TGFB1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN2B—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNA11—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	0.000127	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—E2F1—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—ocular cancer	0.000119	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—E2F1—ocular cancer	0.000117	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—EP300—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MDM2—ocular cancer	9.38e-05	9.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MDM2—ocular cancer	9.18e-05	9.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—ocular cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	8.57e-05	8.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—ocular cancer	8.53e-05	8.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	8.47e-05	8.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1B—ocular cancer	8.38e-05	8.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—ocular cancer	8.29e-05	8.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—ocular cancer	8.17e-05	8.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—ocular cancer	7.99e-05	7.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CDKN1A—ocular cancer	7.73e-05	7.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—ocular cancer	7.7e-05	7.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MDM2—ocular cancer	7.59e-05	7.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—ocular cancer	7.53e-05	7.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EP300—ocular cancer	7.52e-05	7.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EP300—ocular cancer	7.36e-05	7.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MDM2—ocular cancer	7.05e-05	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—ocular cancer	7.05e-05	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1B—ocular cancer	6.93e-05	6.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—ocular cancer	6.86e-05	6.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—EP300—ocular cancer	6.76e-05	6.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—ocular cancer	6.61e-05	6.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—ocular cancer	6.56e-05	6.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	6.55e-05	6.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFB1—ocular cancer	6.54e-05	6.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	6.44e-05	6.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—ocular cancer	6.41e-05	6.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFB1—ocular cancer	6.4e-05	6.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN1A—ocular cancer	6.4e-05	6.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	6.37e-05	6.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—ocular cancer	6.23e-05	6.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—ocular cancer	6.14e-05	6.14e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—ocular cancer	6.12e-05	6.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EP300—ocular cancer	6.09e-05	6.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	5.79e-05	5.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EP300—ocular cancer	5.66e-05	5.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—ocular cancer	5.38e-05	5.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—ocular cancer	5.3e-05	5.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFB1—ocular cancer	5.29e-05	5.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—ocular cancer	5.27e-05	5.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—ocular cancer	5.15e-05	5.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—ocular cancer	5.04e-05	5.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—ocular cancer	4.93e-05	4.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	4.92e-05	4.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—ocular cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—ocular cancer	4.45e-05	4.45e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—EP300—ocular cancer	4.41e-05	4.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—ocular cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—ocular cancer	4.17e-05	4.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—ocular cancer	4.09e-05	4.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—ocular cancer	4.05e-05	4.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—ocular cancer	3.87e-05	3.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—ocular cancer	3.68e-05	3.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—ocular cancer	3.42e-05	3.42e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—ocular cancer	2.66e-05	2.66e-05	CbGpPWpGaD
